Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–11. https://doi.org/10.1056/NEJMra0804577.
CAS Article PubMed PubMed Central Google Scholar
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3(3):203–16. https://doi.org/10.1038/nrc1014.
CAS Article PubMed Google Scholar
Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, Weiss WA. Neuroblastoma. Nat Rev Disease Primers. 2016;2:16078. https://doi.org/10.1038/nrdp.2016.78.
Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet (London, England). 2007;369(9579):2106–20. https://doi.org/10.1016/S0140-6736(07)60983-0.
Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK, Children’s Oncology Group. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010;363(14):1313–23. https://doi.org/10.1056/NEJMoa1001527.
CAS Article PubMed PubMed Central Google Scholar
Strother DR, London WB, Schmidt ML, Brodeur GM, Shimada H, Thorner P, Collins MH, Tagge E, Adkins S, Reynolds CP, Murray K, Lavey RS, Matthay KK, Castleberry R, Maris JM, Cohn SL. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children’s Oncology Group study P9641. J Clinical Oncol. 2012;30(15):1842–8. https://doi.org/10.1200/JCO.2011.37.9990.
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R. Molecular targeting therapies for neuroblastoma: Progress and challenges. Med Res Rev. 2021;41(2):961–1021. https://doi.org/10.1002/med.21750.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17(4):369–86. https://doi.org/10.1080/14737140.2017.1285230.
CAS Article PubMed Google Scholar
Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, Luan G, Yagasaki K, Zhang G. Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology. 2009;59(3):191–200. https://doi.org/10.1007/s10616-009-9211-2.
CAS Article PubMed PubMed Central Google Scholar
Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, Liu X, Liang DS, Lu YJ, Shan HL, Jiang HC. Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cellular Physiol Biochem. 2012;30(3):631–41. https://doi.org/10.1159/000341444.
Zhang J, Li Y, Chen X, Liu T, Chen Y, He W, Zhang Q, Liu S. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep. 2011;26(1):115–24. https://doi.org/10.3892/or.2011.1277.
CAS Article PubMed Google Scholar
Zhang S, Zhang Y, Zhuang Y, Wang J, Ye J, Zhang S, Wu J, Yu K, Han Y. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation. PLoS ONE. 2012;7(10): e46853. https://doi.org/10.1371/journal.pone.0046853.
CAS Article PubMed PubMed Central Google Scholar
Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H, Lu D, Bu H, Zhang R, Lin S. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Oncol Rep. 2013;30(2):589–95. https://doi.org/10.3892/or.2013.2529.
CAS Article PubMed Google Scholar
Zhang X, Hou G, Liu A, Xu H, Guan Y, Wu Y, Deng J, Cao X. Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways. Cell Death Dis. 2019;10(10):770. https://doi.org/10.1038/s41419-019-2013-3.
CAS Article PubMed PubMed Central Google Scholar
Zhang JQ, Li YM, Liu T, He WT, Chen YT, Chen XH, Li X, Zhou WC, Yi JF, Ren ZJ. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World J Gastroenterol. 2010;16(34):4281–90. https://doi.org/10.3748/wjg.v16.i34.4281.
CAS Article PubMed PubMed Central Google Scholar
Li Q, Lai Y, Wang C, Xu G, He Z, Shang X, Sun Y, Zhang F, Liu L, Huang H. Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway. Oncol Rep. 2016;35(1):375–81. https://doi.org/10.3892/or.2015.4341.
CAS Article PubMed Google Scholar
Chang CH, Bijian K, Wernic D, Su J, da Silva SD, Yu H, Qiu D, Asslan M, Alaoui-Jamali MA. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy. Autophagy. 2019;15(8):1376–90. https://doi.org/10.1080/15548627.2019.1582951.
CAS Article PubMed PubMed Central Google Scholar
Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Can Res. 2014;74(3):647–51. https://doi.org/10.1158/0008-5472.CAN-13-2966.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2021;17(1):1–382. https://doi.org/10.1080/15548627.2020.1797280.
Article PubMed PubMed Central Google Scholar
Wu Y, Wang X, Guo H, Zhang B, Zhang XB, Shi ZJ, Yu L. Synthesis and screening of 3-MA derivatives for autophagy inhibitors. Autophagy. 2013;9(4):595–603. https://doi.org/10.4161/auto.23641.
CAS Article PubMed PubMed Central Google Scholar
Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell. 2000;103(2):253–62. https://doi.org/10.1016/s0092-8674(00)00117-3.
CAS Article PubMed Google Scholar
Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175–86. https://doi.org/10.1007/s00412-018-0659-8.
CAS Article PubMed PubMed Central Google Scholar
Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2005;5(9):726–34. https://doi.org/10.1038/nrc1692.
CAS Article PubMed Google Scholar
Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460–73. https://doi.org/10.1089/ars.2013.5371.
CAS Article PubMed PubMed Central Google Scholar
White E, Mehnert JM, Chan CS. Autophagy, metabolism, and cancer. Clinical Cancer Res. 2015;21(22):5037–46. https://doi.org/10.1158/1078-0432.CCR-15-0490.
Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9(9):1167–81. https://doi.org/10.1158/2159-8290.CD-19-0292.
CAS Article PubMed PubMed Central Google Scholar
Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007;14(3):548–58. https://doi.org/10.1038/sj.cdd.4402030.
CAS Article PubMed Google Scholar
Liu R, Li J, Zhang T, Zou L, Chen Y, Wang K, Lei Y, Yuan K, Li Y, Lan J, Cheng L, Xie N, Xiang R, Nice EC, Huang C, Wei Y. Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy. 2014;10(7):1241–55. https://doi.org/10.4161/auto.28912.
CAS Article PubMed PubMed Central Google Scholar
Chude CI, Amaravadi RK. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci. 2017;18(6):1279. https://doi.org/10.3390/ijms18061279.
CAS Article PubMed Central Google Scholar
Qureshi-Baig K, Kuhn D, Viry E, Pozdeev VI, Schmitz M, Rodriguez F, Ullmann P, Koncina E, Nurmik M, Frasquilho S, Nazarov PV, Zuegel N, Boulmont M, Karapetyan Y, Antunes L, Val D, Mittelbronn M, Janji B, Haan S, Letellier E. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway. Autophagy. 2020;16(8):1436–52. https://doi.org/10.1080/15548627.2019.1687213.
CAS Article PubMed Google Scholar
Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E, Martorella A, Alicea GM, Lee JJ, Schuchter LM, Xu X, Herlyn M, Marmorstein R, Amaravadi RK. PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discov. 2019;9(2):220–9. https://doi.org/10.1158/2159-8290.CD-18-0706.
CAS Article PubMed Google Scholar
Dou Q, Chen HN, Wang K, Yuan K, Lei Y, Li K, Lan J, Chen Y, Huang Z, Xie N, Zhang L, Xiang R, Nice EC, Wei Y, Huang C. Ivermectin induces cytostatic autophagy by blocking the PAK1/Akt axis in breast cancer. Can Res. 2016;76(15):4457–69. https://doi.org/10.1158/0008-5472.CAN-15-2887.
Cao C, Subhawong T, Albert JM, Kim KW, Geng L, Sekhar KR, Gi YJ, Lu B. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Can Res. 2006;66(20):10040–7. https://doi.org/10.1158/0008-5472.CAN-06-0802.
Wan Q, Du Z, Fang Z, Cheng H, Li C, Zhou X. Matrine induces apoptosis and autophagy in human lung adenocarcinoma cells via upregulation of Cavin3 and suppression of PI3K/AKT pathway. J BUON. 2020;25(3):1512–6.
留言 (0)